financetom
Business
financetom
/
Business
/
What's Going On With StoneCo Stock Friday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With StoneCo Stock Friday?
Nov 22, 2024 10:59 AM

StoneCo Ltd. ( STNE ) shares are moving higher on Friday after the company announced a share repurchase plan. Here’s what you need to know.

What To Know: Under the plan, Stone plans to repurchase shares worth up to R$ 2 billion ($344.6 million).

The repurchase plan will replace its previous program, announced last year, in which Stone repurchased a total of 13,202,939 shares at an average price of R$ 20.45 per share, totaling R$ 1.03 billion.

“We are pleased to announce the completion of our previous R$1 billion share repurchase program, underscoring our robust financial position. As part of our ongoing commitment to maximizing shareholder returns, we continuously evaluate the most effective use of our resources,” said Pedro Zinner, CEO.

“Confident in our long-term vision, we have approved a new buyback program to seize the current market opportunities. Furthermore, we are finalizing a structured framework to guide our capital allocation strategy, which will enhance transparency and align with our strategic priorities once shared with the market.”

How To Buy StoneCo Shares

By now you're likely curious about how to participate in the market for StoneCo ( STNE ) – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stocks, like Berkshire Hathaway, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.

In the case of StoneCo ( STNE ), which is trading at $10.29 as of publishing time, $100 would buy you 9.72 shares of stock.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

See Also: Cathie Wood’s $3.8 Million Bitcoin Vision Met With Doubt: 83% Say Not By 2030

STNE Price Action: At the time of writing, StoneCo ( STNE ) stock is trading 12.2% higher at $10.41, per data from Benzinga Pro.

Image: Image via Pixabay

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--MGIC Investment Keeps Quarterly Dividend at $0.13 a Share, Payable March 5 to Holders on Feb. 18
--MGIC Investment Keeps Quarterly Dividend at $0.13 a Share, Payable March 5 to Holders on Feb. 18
Jan 28, 2025
03:13 PM EST, 01/28/2025 (MT Newswires) -- Price: 25.49, Change: -0.09, Percent Change: -0.37 ...
Market Chatter: Nvidia Short Sellers Amass $6.6 Billion in Profits Amid Frenzy Over DeepSeek
Market Chatter: Nvidia Short Sellers Amass $6.6 Billion in Profits Amid Frenzy Over DeepSeek
Jan 28, 2025
03:06 PM EST, 01/28/2025 (MT Newswires) -- Bets against Nvidia ( NVDA ) amid a surge in interest for Chinese artificial intelligence app DeepSeek yielded one-day gains of about $6.6 billion for short sellers, Reuters reported Tuesday, citing data analytics firm Ortex. Short positions in Broadcom ( AVGO ) resulted in more than $2 billion in profits, the report added....
US FDA approves Novo Nordisk's Ozempic to reduce diabetic kidney disease progression
US FDA approves Novo Nordisk's Ozempic to reduce diabetic kidney disease progression
Jan 28, 2025
Jan 28 (Reuters) - Novo Nordisk said on Tuesday the U.S. FDA has approved its blockbuster drug Ozempic to lower the risk of progression of chronic kidney disease and the organ's failure, and death due to heart problems in adults with type 2 diabetes. Ozempic belongs to a class of drugs known as GLP-1 receptor agonists and has the same...
Tower Semiconductor Analyst Sees 'Attractive' Buying Opportunity Following DeepSeek Selloff
Tower Semiconductor Analyst Sees 'Attractive' Buying Opportunity Following DeepSeek Selloff
Jan 28, 2025
Benchmark analyst Cody Acree named Tower Semiconductor ( TSEM ) Inc. among recommended oversold names following Monday’s market rout, which was triggered by DeepSeek’s announcement of its advanced language model. Monday’s Selloff: Chinese AI lab DeepSeek unveiled a new large language model reportedly meeting or exceeding leading competitors’ performance at a fraction of the cost. The claims, though met with...
Copyright 2023-2026 - www.financetom.com All Rights Reserved